Zoledronic Acid

Back to search

Molecule Structure

Scientific Name

Zoledronic Acid

Description of the Drug

Zoledronic acid is a bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00399

Brand Name(s)

Aclasta, Reclast, Zerlinda, Zoledronic acid, Zometa

Company Owner(s)

Inforlife Sa, Actavis Inc, Amneal Eu Ltd, Novartis Pharmaceuticals Corp, Emcure Pharmaceuticals Ltd, Akorn Operating Co Llc, Hikma Farmaceutica Sa, Sun Pharma Global Fze, Ingenus Pharmaceuticals Llc, Fresenius Kabi Usa Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Farnesyl diphosphate synthase SINGLE PROTEIN INHIBITOR CHEMBL1782

Unichem Links

SureChEMBL SCHEMBL19054
PharmGKB PA10235
Human Metabolome Database HMDB0014543
DrugBank DB00399
PubChem: Thomson Pharma 14824151
PubChem 68740
Mcule MCULE-1604726355
Nikkaji J556.181G
PDBe ZOL
BindingDB 12578
EPA CompTox Dashboard DTXSID0042668
DrugCentral 2868
Brenda 6184 189166
ChemicalBook CB4395643
Guide to Pharmacology 3177
rxnorm ZOMETA ZOLEDRONIC ACID ANHYDROUS RECLAST ZOLEDRONIC ACID
ChEBI 46557
ZINC ZINC000003803652